Covivio (COV) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
27 Jan, 2026Executive summary
Achieved strong H1 2025 results with 9% revenue growth (+5% like-for-like) and recurring net result up 14% year-over-year to €263m (+6% per share).
Net income reached €341.4 million, a significant turnaround from -€8.4 million in H1 2024.
Portfolio value increased by 3.1% in H1 2025 to over €16bn, with like-for-like growth of 1.5% and a focus on high-quality, centrally located assets.
Upgraded 2025 guidance, now expecting €515m recurring net result (+8% YoY, +4% per share to €4.64), reflecting improved operating performance and financial discipline.
Real estate markets show recovery across all asset classes, with investor confidence returning and large transactions resuming, especially in offices.
Financial highlights
Net revenue increased by 10% to €362m; operating income up 12% to €309.1m, with margin improving to 85%.
Recurring results rose 14% to €263m; recurring earnings per share up 6% after new share issuance.
Net asset value (EPRA NTA) per share at €80.4, up 3.5% year-over-year and 0.7% in H1, despite full dividend payment.
LTV ratio at 39.8%, net debt to EBITDA improved from 11.4x to 10.7x.
High occupancy rates: 97.3% overall, 95.5% offices, 99.0% German residential, 100% hotels.
Outlook and guidance
2025 recurring net result guidance raised to €515 million (+8% vs. 2024, +4% per share to €4.64).
Like-for-like revenue growth expected to remain robust at +5%.
Optimism for H2 2025 driven by improved market conditions, cost stabilization, and accretive acquisitions.
Debt metrics expected to further improve, with LTV targeted below 39%.
Ongoing focus on portfolio quality, asset rotation, and ESG-linked financing.
Latest events from Covivio
- Recurring net result per share up 6.4%, NAV per share up 3.9%, and 2026 targets 4% further growth.COV
H2 202520 Feb 2026 - Revenue up 4.8% with 2025 guidance confirmed; strong operations and ESG leadership.COV
Q3 202520 Feb 2026 - Recurring net result up 3.3%, guidance raised, and hotel exposure increased to 20%.COV
H1 20243 Feb 2026 - Q1 2025 revenue up 5.4%, with high occupancy and guidance and dividend increase confirmed.COV
Q1 202527 Jan 2026 - Revenue up 6.8% like-for-like, occupancy at 97.3%, and €391m in disposals signed.COV
Q3 202419 Jan 2026 - Balanced growth, centrality, and ESG leadership drive portfolio transformation to 2030.COV
CMD 202412 Jan 2026 - Recurring net income up 10% and dividend up 6%, with 2025 guidance for further growth.COV
Q4 202417 Dec 2025